PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1424960
PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1424960
Pyrogen Testing Market Size and Share Analysis by Offering, Type, End User - Global Industry Demand Forecast to 2030
Revenue of USD 1,406.4 million was generated in the global Pyrogen Test Market for 2023, which is expected to grow at a compound annual growth rate of 7.3% over the period from 2024 to 2030 and reach USD 2,284.2 million. This growth of the market can be credited to the increasing acceptance of pyrogen testing within the biopharmaceutical sector.
Furthermore, the rising development in the biotechnology and pharmaceutical industries along with the increasing count of new biologics research and introductions is projected to fuel the demand for these testing for making safe and better drugs.
Pyrogen testing is a vital step for each medication and therapeutics to make it safer and more effective. Surge in the count of cancer cases and hereditary illnesses, modified treatments attained benefits in the treatment of these diseases.
Tailored medicine has the benefit that it uses people's hereditary profiles to aid in decision-making for the prevention, diagnosis, and treatment of illnesses. Therefore, patients and businesses are quickly accepting modified drugs. Furthermore, modified treatment-based methods to clinical and genomic features are becoming more popular among patients with cancer and immunologic sicknesses. Hence, the increasing need for modified drugs is one of the key reasons propelling the demand for pyrogen testing solutions.
On the basis of the end user, the category of pharmaceutical and biotechnology companies accounted for the largest revenue share of 35% in 2023 and is expected to remain so in the future. This has been driven by the increase in the manufacturing of medicines, biologics, and new drugs as well as a growing demand for pyrogen testing. In addition, the market growth in this category is being driven by a growing preference for personalized medicine as well as an increasing incidence of infectious and chronic diseases.
The foremost sales generator in 2023, North America accounted for the highest market percentage of 55%. That is due to the continuing growths in biotechnology and pharmaceutical wherein cookies are used to make your experience better. Other key factors that have contributed to the increase of the local marketplace consist of an extended pipeline of prescribed drugs, an upward thrust in drug approvals as well as growing awareness about product safety and food security.
In the North American region, the U.S. dominates the industry. This is mainly because of the existence of advanced healthcare infrastructure, augmented concentration on new drug growth, and the presence of key biotechnology and biopharmaceutical companies, like Pfizer Inc. and F. Hoffmann-La Roche AG, in the country.
Furthermore, Canada is also generating substantial revenue for the North American industry. This can be credited to the rising pharmaceutical and biotechnology sector, the rising awareness regarding the safety of medications, and the growing R&D activities in the country.
Top Providers of Pyrogen Testing Are:
Charles River Laboratories International Inc.
Merck KGaA
Thermo Fisher Scientific Inc.
FUJIFILM Wako Pure Chemical Corporation
WuXi AppTec Co. Ltd.
Microcoat Biotechnologie GmbH
Nelson Laboratories LLC
Lonza Group Ltd.
Ellab A/S
GenScript Biotech Corporation
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by type
- 1.4.2. Market size breakdown, by application
- 1.4.3. Market size breakdown, by animal
- 1.4.4. Market size breakdown, by end user
- 1.4.5. Market size breakdown, by region
- 1.4.6. Market size breakdown, by country
- 1.5. Market Data Reporting Unit
- 1.5.1. Value
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
- 5.1. Market Dynamics
- 5.1.1. Trends
- 5.1.2. Drivers
- 5.1.3. Restraints/challenges
- 5.1.4. Impact analysis of drivers/restraints
- 5.2. Impact of COVID-19
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Bargaining power of buyers
- 5.3.2. Bargaining power of suppliers
- 5.3.3. Threat of new entrants
- 5.3.4. Intensity of rivalry
- 5.3.5. Threat of substitutes
Chapter 6. Global Market
- 6.1. Overview
- 6.2. Market Revenue, by Type (2017-2030)
- 6.3. Market Revenue, by Application (2017-2030)
- 6.3.1. Surgery market revenue, by type (2017-2030)
- 6.4. Market Revenue, by Animal (2017-2030)
- 6.5. Market Revenue, by End User (2017-2030)
- 6.6. Market Revenue, by Region (2017-2030)
Chapter 7. North America Market
- 7.1. Overview
- 7.2. Market Revenue, by Type (2017-2030)
- 7.3. Market Revenue, by Application (2017-2030)
- 7.3.1. Surgery market revenue, by type (2017-2030)
- 7.4. Market Revenue, by Animal (2017-2030)
- 7.5. Market Revenue, by End User (2017-2030)
- 7.6. Market Revenue, by Country (2017-2030)
Chapter 8. Europe Market
- 8.1. Overview
- 8.2. Market Revenue, by Type (2017-2030)
- 8.3. Market Revenue, by Application (2017-2030)
- 8.3.1. Surgery market revenue, by type (2017-2030)
- 8.4. Market Revenue, by Animal (2017-2030)
- 8.5. Market Revenue, by End User (2017-2030)
- 8.6. Market Revenue, by Country (2017-2030)
Chapter 9. APAC Market
- 9.1. Overview
- 9.2. Market Revenue, by Type (2017-2030)
- 9.3. Market Revenue, by Application (2017-2030)
- 9.3.1. Surgery market revenue, by type (2017-2030)
- 9.4. Market Revenue, by Animal (2017-2030)
- 9.5. Market Revenue, by End User (2017-2030)
- 9.6. Market Revenue, by Country (2017-2030)
Chapter 10. LATAM Market
- 10.1. Overview
- 10.2. Market Revenue, by Type (2017-2030)
- 10.3. Market Revenue, by Application (2017-2030)
- 10.3.1. Surgery market revenue, by type (2017-2030)
- 10.4. Market Revenue, by Animal (2017-2030)
- 10.5. Market Revenue, by End User (2017-2030)
- 10.6. Market Revenue, by Country (2017-2030)
Chapter 11. MEA Market
- 11.1. Overview
- 11.2. Market Revenue, by Type (2017-2030)
- 11.3. Market Revenue, by Application (2017-2030)
- 11.3.1. Surgery market revenue, by type (2017-2030)
- 11.4. Market Revenue, by Animal (2017-2030)
- 11.5. Market Revenue, by End User (2017-2030)
- 11.6. Market Revenue, by Country (2017-2030)
Chapter 12. U.S. Market
- 12.1. Overview
- 12.2. Market Revenue, by Type (2017-2030)
- 12.3. Market Revenue, by Application (2017-2030)
- 12.3.1. Surgery market revenue, by type (2017-2030)
- 12.4. Market Revenue, by Animal (2017-2030)
- 12.5. Market Revenue, by End User (2017-2030)
Chapter 13. Canada Market
- 13.1. Overview
- 13.2. Market Revenue, by Type (2017-2030)
- 13.3. Market Revenue, by Application (2017-2030)
- 13.3.1. Surgery market revenue, by type (2017-2030)
- 13.4. Market Revenue, by Animal (2017-2030)
- 13.5. Market Revenue, by End User (2017-2030)
Chapter 14. Germany Market
- 14.1. Overview
- 14.2. Market Revenue, by Type (2017-2030)
- 14.3. Market Revenue, by Application (2017-2030)
- 14.3.1. Surgery market revenue, by type (2017-2030)
- 14.4. Market Revenue, by Animal (2017-2030)
- 14.5. Market Revenue, by End User (2017-2030)
Chapter 15. France Market
- 15.1. Overview
- 15.2. Market Revenue, by Type (2017-2030)
- 15.3. Market Revenue, by Application (2017-2030)
- 15.3.1. Surgery market revenue, by type (2017-2030)
- 15.4. Market Revenue, by Animal (2017-2030)
- 15.5. Market Revenue, by End User (2017-2030)
Chapter 16. U.K. Market
- 16.1. Overview
- 16.2. Market Revenue, by Type (2017-2030)
- 16.3. Market Revenue, by Application (2017-2030)
- 16.3.1. Surgery market revenue, by type (2017-2030)
- 16.4. Market Revenue, by Animal (2017-2030)
- 16.5. Market Revenue, by End User (2017-2030)
Chapter 17. Italy Market
- 17.1. Overview
- 17.2. Market Revenue, by Type (2017-2030)
- 17.3. Market Revenue, by Application (2017-2030)
- 17.3.1. Surgery market revenue, by type (2017-2030)
- 17.4. Market Revenue, by Animal (2017-2030)
- 17.5. Market Revenue, by End User (2017-2030)
Chapter 18. Spain Market
- 18.1. Overview
- 18.2. Market Revenue, by Type (2017-2030)
- 18.3. Market Revenue, by Application (2017-2030)
- 18.3.1. Surgery market revenue, by type (2017-2030)
- 18.4. Market Revenue, by Animal (2017-2030)
- 18.5. Market Revenue, by End User (2017-2030)
Chapter 19. Japan Market
- 19.1. Overview
- 19.2. Market Revenue, by Type (2017-2030)
- 19.3. Market Revenue, by Application (2017-2030)
- 19.3.1. Surgery market revenue, by type (2017-2030)
- 19.4. Market Revenue, by Animal (2017-2030)
- 19.5. Market Revenue, by End User (2017-2030)
Chapter 20. China Market
- 20.1. Overview
- 20.2. Market Revenue, by Type (2017-2030)
- 20.3. Market Revenue, by Application (2017-2030)
- 20.3.1. Surgery market revenue, by type (2017-2030)
- 20.4. Market Revenue, by Animal (2017-2030)
- 20.5. Market Revenue, by End User (2017-2030)
Chapter 21. India Market
- 21.1. Overview
- 21.2. Market Revenue, by Type (2017-2030)
- 21.3. Market Revenue, by Application (2017-2030)
- 21.3.1. Surgery market revenue, by type (2017-2030)
- 21.4. Market Revenue, by Animal (2017-2030)
- 21.5. Market Revenue, by End User (2017-2030)
Chapter 22. Australia Market
- 22.1. Overview
- 22.2. Market Revenue, by Type (2017-2030)
- 22.3. Market Revenue, by Application (2017-2030)
- 22.3.1. Surgery market revenue, by type (2017-2030)
- 22.4. Market Revenue, by Animal (2017-2030)
- 22.5. Market Revenue, by End User (2017-2030)
Chapter 23. South Korea Market
- 23.1. Overview
- 23.2. Market Revenue, by Type (2017-2030)
- 23.3. Market Revenue, by Application (2017-2030)
- 23.3.1. Surgery market revenue, by type (2017-2030)
- 23.4. Market Revenue, by Animal (2017-2030)
- 23.5. Market Revenue, by End User (2017-2030)
Chapter 24. Brazil Market
- 24.1. Overview
- 24.2. Market Revenue, by Type (2017-2030)
- 24.3. Market Revenue, by Application (2017-2030)
- 24.3.1. Surgery market revenue, by type (2017-2030)
- 24.4. Market Revenue, by Animal (2017-2030)
- 24.5. Market Revenue, by End User (2017-2030)
Chapter 25. Mexico Market
- 25.1. Overview
- 25.2. Market Revenue, by Type (2017-2030)
- 25.3. Market Revenue, by Application (2017-2030)
- 25.3.1. Surgery market revenue, by type (2017-2030)
- 25.4. Market Revenue, by Animal (2017-2030)
- 25.5. Market Revenue, by End User (2017-2030)
Chapter 26. Saudi Arabia Market
- 26.1. Overview
- 26.2. Market Revenue, by Type (2017-2030)
- 26.3. Market Revenue, by Application (2017-2030)
- 26.3.1. Surgery market revenue, by type (2017-2030)
- 26.4. Market Revenue, by Animal (2017-2030)
- 26.5. Market Revenue, by End User (2017-2030)
Chapter 27. South Africa Market
- 27.1. Overview
- 27.2. Market Revenue, by Type (2017-2030)
- 27.3. Market Revenue, by Application (2017-2030)
- 27.3.1. Surgery market revenue, by type (2017-2030)
- 27.4. Market Revenue, by Animal (2017-2030)
- 27.5. Market Revenue, by End User (2017-2030)
Chapter 28. U.A.E. Market
- 28.1. Overview
- 28.2. Market Revenue, by Type (2017-2030)
- 28.3. Market Revenue, by Application (2017-2030)
- 28.3.1. Surgery market revenue, by type (2017-2030)
- 28.4. Market Revenue, by Animal (2017-2030)
- 28.5. Market Revenue, by End User (2017-2030)
Chapter 29. Competitive Landscape
- 29.1. List of Market Players and their Offerings
- 29.2. Competitive Benchmarking of Key Players
- 29.3. Product Benchmarking of Key Players
- 29.4. Recent Strategic Developments
Chapter 30. Company Profiles
- 30.1. Charles River Laboratories International Inc.
- 30.1.1. Business overview
- 30.1.2. Product and service offerings
- 30.1.3. Key financial summary
- 30.2. Merck KGaA
- 30.2.1. Business overview
- 30.2.2. Product and service offerings
- 30.2.3. Key financial summary
- 30.3. Thermo Fisher Scientific Inc.
- 30.3.1. Business overview
- 30.3.2. Product and service offerings
- 30.3.3. Key financial summary
- 30.4. FUJIFILM Wako Pure Chemical Corporation
- 30.4.1. Business overview
- 30.4.2. Product and service offerings
- 30.4.3. Key financial summary
- 30.5. WuXi AppTec Co. Ltd.
- 30.5.1. Business overview
- 30.5.2. Product and service offerings
- 30.5.3. Key financial summary
- 30.6. Microcoat Biotechnologie GmbH
- 30.6.1. Business overview
- 30.6.2. Product and service offerings
- 30.6.3. Key financial summary
- 30.7. Nelson Laboratories LLC
- 30.7.1. Business overview
- 30.7.2. Product and service offerings
- 30.7.3. Key financial summary
- 30.8. Lonza Group Ltd.
- 30.8.1. Business overview
- 30.8.2. Product and service offerings
- 30.8.3. Key financial summary
- 30.9. Ellab A/S
- 30.9.1. Business overview
- 30.9.2. Product and service offerings
- 30.9.3. Key financial summary
- 30.10. GenScript Biotech Corporation
- 30.10.1. Business overview
- 30.10.2. Product and service offerings
- 30.10.3. Key financial summary
Chapter 31. Appendix
- 31.1. Abbreviations
- 31.2. Sources and References
- 31.3. Related Reports
